Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820193 · ClinicalTrials.gov registry record · Early Phase 1
Nonopioid Analgesia After Arthroscopic Meniscus Surgery
A Early Phase 1 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 61
- Enrollment target
NCT03820193: Completed Early Phase 1 study, sponsored by Henry Ford Health System.
NCT03820193 is a Early Phase 1 study that has completed, run by Henry Ford Health System. The registered enrollment target is 61 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03820193, a Early Phase 1 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of arthroscopic meniscus surgery: a treatment group given a non-opioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Primary Outcome
Patients record pain levels every 3 hours using Visual analog scales for 10 days post-operatively. Average daily pain was calculated for each patient. Higher values portend worse control.
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Celecoxib
- DRUG Gabapentin
- DRUG Hydrocodon/Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2021-01-20 |
| Phase | Early Phase 1 |
What the finished NCT03820193 record still lists
NCT03820193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% higher).
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT03820193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03820193 about?
NCT03820193 is a clinical study titled "Nonopioid Analgesia After Arthroscopic Meniscus Surgery". This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of arthroscopic meniscus surgery: a treatment group given a non-opioid pain control regimen, and a standard of care control grou...
What is the current status of trial NCT03820193?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 61 participants. The study started on 2019-01-22. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT03820193?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Celecoxib (DRUG), Gabapentin (DRUG), Hydrocodon/Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03820193?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03820193's enrollment target sits among peer trials
61 397th of 2000 higher than 1,599 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI